ArticleClinical & translational immunology2026
Prolonged molecular control during intermittent reduced-intensity blinatumomab maintenance in a transplant-ineligible patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia and
Xiaoqian Duan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.